Improvement of inactivated influenza virus vaccines

Journal of Infectious Diseases

Volumn 176, Issue SUPPL. 1, 1997, Pages

  Couch, Robert B ^a,b   Keitel, Wendy A ^a   Cate, Thomas R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Dept of Microbiology and Immunology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT; INFLUENZA VACCINE; SECRETORY IMMUNOGLOBULIN; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

ANTIBODY RESPONSE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; EPIDEMIC; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030800956     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514173     Document Type: Conference Paper

References (14)

1. Advisory Committee on Immunization Practices. Prevention and control of influenza. MMWR Morb Mortal Wkly Rep 1995;44(RR-3):1-22.
2. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults. Ann Intern Med 1988;108:616-25.
3. Davenport FM, Hennessy AV, Brandon FM, et al. Comparison of serological and febrile responses in humans to vaccination with influenza A viruses of their haemagglutinins. J Lab Clin Med 1964;63:5-13.
4. Couch RB, Quarks JM, Cate TR, Zahradnik JM. Clinical trials with live cold-reassortant influenza virus vaccines. In: Kendal AP, Patriarca PA, eds. Options for the control of influenza. New York; Alan R Liss, 1986:223-41. (UCLA Symposia on Molecular and Cellular Biology; vol 36).
5. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988;127:353-64.
6. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis 1991;163:300-4.
7. Piedra PA, Glezen WP. Influenza in children: epidemiology, immunity, and vaccines. Semin Pediatr Infect Dis 1991;2:140-6.
8. Govaert ME, Thijs CTM, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. JAMA 1994;272:1661-5.
9. Rapmund G, Johnson RT, Bankhead AS, Herman YF, Dandridge OW. The diagnosis of Asian influenza virus infection after recent immunization. US Armed Forces Med J 1959;10:637-49.
10. Couch RB, Kasel JA. Immunity to influenza in man. Annu Rev Microbiol 1983;37:529-49.
11. Couch RB, Kasel JA, Six HR, Cate TR, Zahradnik JM. Immunological reactions and resistance to infection with influenza virus. In: Stuart-Harris C, Potter C, eds. Molecular virology and epidemiology of influenza. London: Academic Press, 1984;119-53.
12. Dowdle WR, Downie JC, Laver WG. Inhibition of virus release by antibodies to surface antigens of influenza virus. J Virol 1974;13:269-75.
13. Monto AS, Kendal AP. Effect of neuraminidase antibody on Hong Kong influenza. Lancet 1973;1:623-5.
14. Ennis FA, Rook AH, Hua QY, et al. HLA-restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza viruses. Lancet 1981;2:887-91.